Yamada-Lifton will lead a center for operational excellence that will oversee operations for Maypro Group’s subsidiaries, including its global nutraceutical distribution business.
Maypro Group (Purchase, NY) hired May Yamada-Liftonas chief operating officer (COO). In this role, she will support business leaders in a variety of areasincluding marketing strategy, business innovation through new products and methodologies, as well as the evaluation and allocation of resources to enable global growth. Yamada-Lifton will lead a center for operational excellence that will oversee operations for Maypro Group’s subsidiaries, including its global nutraceutical distribution business. She has 20 years of leadership experience with companies such Pfizer, SAS, and CSL Behring.
“As Maypro enters its 45th year, we are preparing for dramatic growth,” said Steve Yamada, founder/chairman of Maypro Group, in a press release. “Yamada-Lifton will not only unify our operating businesses in the United States, Japan, and China, but she will introduce best practices in marketing, sales, innovation, and human resources based on her experiences leading Fortune 100 companies and organizations designated as ‘Best Companies to Work For.’ Her ability to leverage data mining, analysis, and forecasting systems will be integral to Maypro’s growth and add value to its customers globally.”
Gencor to distribute Gnosis by Lesaffre’s Landkind Pure Salidroside in the United States
September 11th 2024The ingredient is manufactured by Gnosis by Lesaffre as an alternative to rhodiola extract. Salidroside is the most studied bioactive in rhodiola, to which the extract efficacy is attributed to.
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.